Genscript Probio And Rvac Medicines Announce Strategic Partnership For Gmp Plasmid Dna Manufacturing For Mrna Covid-19 Vaccine Candidate

Genscript Probio A Leading Global Contract Development And Manufacturing Organization (Cdmo), And Rvac Medicines Pte. Ltd., A Biotechnology Company Focusing On The Development And Commercialization Of Messenger Rna (Mrna) Therapeutics And Vaccines, Today Announced An Agreement To Establish A Strategic Partnership For The Manufacturing Of Gmp-Grade Plasmid Dna (Pdna) For Its Mrna Covid-19 Vaccine Candidate, Rvm-V001, Along With Collaboration For Future Therapeutic Pipelines. Genscript Probio Will Provide Gmp Plasmid Manufacturing Service For Rvac Medicines' Program, Rvm-V001. This Partnership Will Enable To Accelerate Its Clinical Manufacturing Of Mrna-Based Covid-19 Vaccine, Rvm-V001, And Future Mrna-Based Vaccines Targeting Infectious Diseases Such As Respiratory Syncytial Virus (Rsv) And Clostriodioides Difficile Infection (Cdi).Dr. Brian Min, Ceo Of Genscript Probio Said, "We Are Delighted To Enter Into This Strategic Partnership With Rvac Medicines. This Collaboration Will Enable Us To Utilize Our Cutting-Edge Gmp Plasmid Manufacturing Platform Technology To Support The Development Of Mrna-Based Covid-19 Vaccine And Its Therapeutic Candidates."Dr. Sean Fu, Ceo Of Rvac Medicines Said, "We Are Excited To Work Closely With Genscript Probio. With Its Technical Strength And Customer Centric Approach, Genscript Probio Will Help To Accelerate The Development Of Rvac'S Pipeline."As Rvac Advances The Development Of Its Mrna Candidates, Genscript Probio Continues To Provide High-Quality Gmp Materials Critical To The Mission, Including Plasmid Dna And The Development Of Ancillary Materials To Support Mrna Manufacturing Process. In Addition To The Manufacturing Of Plasmid Dna, The Genscript Probio Team Provides Consultative And Expert Guidance Regarding Quality And Regulatory Expectations Of Agencies Worldwide.Rvac Medicines Will Continue To Collaborate With Genscript Probio To Support Its Mrna Initiatives For Both Clinical-Stage Development And Commercial Stage.About Rvac MedicinesRvac Medicines Is An Mrna Platform Company Headquartered In Singapore With R&D Centers In Boston, Ma And Shanghai, Cn. Leveraging Its Mrna Technology And Strategic Partnerships, The Company Is Building A Pipeline Of Novel Mrna Vaccines And Therapeutics To Address Unmet Medical Needs, Particularly In Emerging Markets. Genscript Probio, A Subsidiary Of Genscript Biotech Corporation, Offers End-To-End Cdmo Services From Drug Discovery To Commercialization With Proactive Strategies, Professional Solutions And Efficient Processes In Cgt, Vaccine, Biologics Discovery And Antibody Protein Drug, Aiming To Accelerate Drug Development For Customers. Genscript Probio Has Established Companies In The United States, The Netherlands, South Korea, And China (Hong Kong, Shanghai, And Nanjing) And Other Regions To Serve Global Customers, And Has Helped Customers In The United States, Europe, Asia Pacific And Other Regions Obtain More Than 40 Ind Approvals Since October 2017.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!